Health
Healthcare access, pharmaceutical pricing, and the algorithmic management of medical systems. Insurance algorithms denying claims at scale, pharmaceutical companies optimizing pricing for extraction rather than access, hospital systems consolidating under private equity, medical debt as a leading cause of bankruptcy, and the growing gap between what healthcare technology can do and who is allowed to benefit from it.
These lab-grown insulin cells reverse diabetes in mice and clear a major hurdle for type 1 treatment